In the last 12 months, insiders at Kuvatris Therapeutics, Inc. ($PXMD) filed 14 transactions with the SEC: 0 open-market purchases totaling $0 and 4 sales totaling $615. Net insider sentiment: net selling.
Kuvatris Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Rome Zachary (Director) — 2 transactions totaling $3,773
- Sheldon Stephen (CFO and COO) — 2 transactions totaling $2,476
- Weisman Howard J. (Chief Executive Officer) — 2 transactions totaling $2,194
- Hough David W. (Chief Medical Officer) — 2 transactions totaling $1,194
- CASAMENTO CHARLES J (Director) — 2 transactions totaling $758
View all SEC Filings for Kuvatris Therapeutics, Inc. (PXMD).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2024 | CASAMENTO CHARLES J | Director | F | Common Stock | 992 | $0.69 | 2,386.0000 | 1,662,795 | 29.37% | 0.06% |
| March 12, 2024 | Weisman Howard J. | Chief Executive Officer | F | Common Stock | 2927 | $0.69 | 34,748.0000 | 1,662,795 | 7.77% | 0.18% |
| March 12, 2024 | Sheldon Stephen | CFO and COO | F | Common Stock | 3356 | $0.69 | 11,243.0000 | 1,662,795 | 22.99% | 0.20% |
| March 12, 2024 | Rome Zachary | Director | F | Common Stock | 4904 | $0.69 | 10,244.0000 | 1,662,795 | 32.37% | 0.29% |
| March 12, 2024 | LaRochelle Karen | Director | F | Common Stock | 604 | $0.69 | 2,225.0000 | 1,662,795 | 21.35% | 0.04% |
| March 12, 2024 | Hough David W. | Chief Medical Officer | F | Common Stock | 1452 | $0.69 | 5,905.0000 | 1,662,795 | 19.74% | 0.09% |
| March 12, 2024 | Coelho John F | Director | F | Common Stock | 207 | $0.69 | 4,408.0000 | 1,662,795 | 4.49% | 0.01% |
| Feb. 21, 2024 | Hough David W. | Chief Medical Officer | F | Common Stock | 291 | $0.66 | 7,357.0000 | 1,662,795 | 3.80% | 0.02% |
| Feb. 21, 2024 | Sheldon Stephen | CFO and COO | F | Common Stock | 243 | $0.66 | 14,599.0000 | 1,662,795 | 1.64% | 0.01% |
| Jan. 29, 2024 | Weisman Howard J. | Chief Executive Officer | S | Common Stock | 372 | $0.47 | 37,675.0000 | 1,662,795 | 0.98% | 0.02% |
| Jan. 29, 2024 | LaRochelle Karen | Director | S | Common Stock | 78 | $0.48 | 2,829.0000 | 1,662,795 | 2.68% | 0.00% |
| Jan. 29, 2024 | Coelho John F | Director | S | Common Stock | 27 | $0.48 | 4,615.0000 | 1,662,795 | 0.58% | 0.00% |
| Jan. 29, 2024 | CASAMENTO CHARLES J | Director | F | Common Stock | 97 | $0.76 | 3,378.0000 | 1,662,795 | 2.79% | 0.01% |
| Jan. 29, 2024 | Rome Zachary | Director | S | Common Stock | 811 | $0.48 | 15,148.0000 | 1,662,795 | 5.08% | 0.05% |